Moreover, combining a CSF1R inhibitor with a CXCR2 inhibitor was shown to block granulocyte infiltration of tumors triggered by the inhibition of CSF1R and significantly reduce tumor growth (Kumar et al., 2017). This evidence concerns the gene CSF1R and neoplasm.